28 April 2020

Dr. Kongkrapan Intarajang, CEO of GC, together with his executive team, present CoviClear, or the silver nanoparticle disinfection unit to help reduce the risk of COVID-19 transmission to Chulalongkorn Hospital, the Thai Red Cross Society

Share:

Dr. Kongkrapan Intarajang, Chief Executive Officer of GC, and his executive team presented CoviClear or the silver nanoparticle disinfection unit, which is designed to help lower the risk of contracting COVID-19 along with raw materials in producing two types of disinfectant liquid namely; triethanolamine (TEA) for which GC is the only manufacturer in Thailand, and Pharmaceutical-grade glycerine for use in CoviClear to Chulalongkorn Hospital, the Thai Red Cross Society in which the donation was received by Prof. Dr. Suttipong Wacharasindhu, Dean of the Faculty of Medicine, Chulalongkorn University, Assoc. Prof. Dr. Chanchai Sittipunt, Associate Dean for Planning and Development Department, and Asst. Prof. Dr. Nakarin Sirisabya, Assistant Dean for Planning and Development Department, Faculty of Medicine, Chulalongkorn University.

CoviClear is an innovation developed by GC that increases the disinfection and prevention of germs by releasing silver nanoparticles through a micron-sized nozzle in the form of a vapor. The vapor pairs the silver nanoparticles with viruses, bacteria and other diseases which a person carries, including on their clothing, killing them on contact without causing any harm.

News

News
27 June 2024
GC ร่วมมือซาบีน่าในโครงการ เย็บเต้ารวมใจ สู้ภัยมะเร็งเต้านม ต่อเนื่องปีที่ 18
Read More
News
30 April 2020
GC and ThaiBev produce 1 million bottles of hand sanitizer gel for Village Health Volunteers to tackle COVID-19 [Khao Sod]
Read More
News
09 April 2020
GC moves forward developing plastic innovations for the medical profession and providing materials for the production of protective suits to support the fight against COVID-19 [Matichon]
Read More